FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

36603911000001102: Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Feb 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
112472201000001115 Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
112472301000001112 Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose Has NHS dm+d (dictionary of medicines and devices) freeness indicator CFC free true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose Has dispensed dose form Pressurised inhalation true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose Is a Beclometasone 250micrograms/actuation inhaler CFC free 200 dose true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose Has AMP Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose Has specific active ingredient Beclometasone dipropionate true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose Has dispensed dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Soprobec 250micrograms/dose inhaler (Glenmark Pharmaceuticals Europe Ltd) 200 dose VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start